C21 Investments Financial Health

Short Term Liabilities: CXXI's short term assets ($10.6M) do not cover its short term liabilities ($14.5M).

Long Term Liabilities: CXXI's short term assets ($10.6M) exceed its long term liabilities ($9.1M).

Debt Level: CXXI's net debt to equity ratio (6.4%) is considered satisfactory.

Reducing Debt: CXXI's debt to equity ratio has increased from 0% to 12.5% over the past 5 years.

Debt Coverage: CXXI's debt is well covered by operating cash flow (143.1%).

Interest Coverage: CXXI's interest payments on its debt are well covered by EBIT (10.5x coverage).

• Healthy companies in the Pharmaceuticals & Biotech industry.